{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T20:20:10Z","timestamp":1787343610229,"version":"build-2736575974"},"reference-count":124,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042022dx0003"],"award-info":[{"award-number":["2042022dx0003"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2504200"],"award-info":[{"award-number":["2022YFC2504200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472818"],"award-info":[{"award-number":["82472818"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273202"],"award-info":[{"award-number":["82273202"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bbcan.2025.189278","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T16:06:12Z","timestamp":1739030772000},"page":"189278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lymphangiogenesis orchestrating tumor microenvironment: Face changing in immunotherapy"],"prefix":"10.1016","volume":"1880","author":[{"given":"Jun-Ye","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Jun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2025.189278_bb0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12307-012-0119-6","article-title":"Molecular regulation of lymphangiogenesis in development and tumor microenvironment","volume":"5","author":"Li","year":"2012","journal-title":"Cancer Microenviron."},{"key":"10.1016\/j.bbcan.2025.189278_bb0010","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3389\/fimmu.2019.00470","article-title":"Regulation of immune function by the lymphatic system in lymphedema","volume":"10","author":"Kataru","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0015","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1186\/s12935-021-02299-8","article-title":"Immune checkpoint blockade in the treatment of malignant tumor: current statue and future strategies","volume":"21","author":"Yang","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2025.189278_bb0020","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1172\/JCI79434","article-title":"Lymphatic vessels regulate immune microenvironments in human and murine melanoma","volume":"126","author":"Lund","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2025.189278_bb0025","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1182278","article-title":"The dual role of tumor lymphatic vessels in dissemination of metastases and immune response development","volume":"5","author":"Stachura","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2025.189278_bb0030","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3389\/fimmu.2019.00720","article-title":"Tumor-associated lymphatic vessel features and lmmunomodulatory functions","volume":"10","author":"Garnier","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1413067","article-title":"Mature tertiary lymphoid structures: important contributors to anti-tumor immune efficacy","volume":"15","author":"Bao","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0040","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3389\/fimmu.2016.00491","article-title":"High endothelial venules and lymphatic vessels in tertiary lymphoid organs: characteristics, functions, and regulation","volume":"7","author":"Ruddle","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41568-024-00681-y","article-title":"Lymphatic vessels in the age of cancer immunotherapy","volume":"24","author":"Karakousi","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2025.189278_bb0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3677","article-title":"Lymphangiogenesis and lymphatic vessel remodelling in cancer","volume":"14","author":"Stacker","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2025.189278_bb0055","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.canlet.2014.11.035","article-title":"Metastasis-associated in colon cancer-1 upregulates vascular endothelial growth factor-C\/D to promote lymphangiogenesis in human gastric cancer","volume":"357","author":"Sun","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2025.189278_bb0060","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.canlet.2018.01.040","article-title":"NRP-2 in tumor lymphangiogenesis and lymphatic metastasis","volume":"418","author":"Wang","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2025.189278_bb0065","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.1158\/0008-5472.CAN-05-0408","article-title":"Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor","volume":"65","author":"Lin","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189278_bb0070","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/84635","article-title":"VEGF-D promotes the metastatic spread of tumor cells via the lymphatics","volume":"7","author":"Stacker","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2025.189278_bb0075","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1158\/0008-5472.CAN-18-3657","article-title":"Activation of the VEGFC\/VEGFR3 pathway induces tumor immune escape in colorectal cancer","volume":"79","author":"Tacconi","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189278_bb0080","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1084\/jem.20041896","article-title":"VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis","volume":"201","author":"Hirakawa","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2025.189278_bb0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev-med-051419-114417","article-title":"Lymphatic vasculature: an emerging therapeutic target and drug delivery route","volume":"72","author":"Xu","year":"2021","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbcan.2025.189278_bb0090","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1078-0432.CCR-22-1366","article-title":"Molecular mechanisms and future implications of VEGF\/VEGFR in cancer therapy","volume":"29","author":"Patel","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189278_bb0095","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1152\/physrev.00039.2021","article-title":"Lymphatic vessels in cancer","volume":"102","author":"Dieterich","year":"2022","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbcan.2025.189278_bb0100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccr.2011.12.026","article-title":"VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium","volume":"21","author":"Karnezis","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2025.189278_bb0105","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1158\/0008-5472.CAN-03-1301","article-title":"Cyclooxygenase-2 induces EP1- and HER-2\/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma","volume":"64","author":"Su","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189278_bb0110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1756-9966-30-14","article-title":"Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications","volume":"30","author":"Gou","year":"2011","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189278_bb0115","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1158\/1078-0432.CCR-12-0708","article-title":"The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis","volume":"18","author":"Zhuo","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189278_bb0120","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1038\/ncomms5944","article-title":"TNFR1 mediates TNF-\u03b1-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling","volume":"5","author":"Ji","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2025.189278_bb0125","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10456-013-9386-1","article-title":"Src contributes to IL6-induced vascular endothelial growth factor-C expression in lymphatic endothelial cells","volume":"17","author":"Huang","year":"2014","journal-title":"Angiogenesis"},{"key":"10.1016\/j.bbcan.2025.189278_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12197","article-title":"Melanoma-derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes","volume":"11","author":"Leary","year":"2022","journal-title":"J. Extracell. Vesicl."},{"key":"10.1016\/j.bbcan.2025.189278_bb0135","doi-asserted-by":"crossref","first-page":"15894","DOI":"10.1073\/pnas.1208324109","article-title":"Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis","volume":"109","author":"Cao","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2025.189278_bb0140","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7510496","article-title":"S1P provokes tumor lymphangiogenesis via macrophage-derived mediators such as IL-1\u03b2 or lipocalin-2","volume":"2017","author":"Syed","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bbcan.2025.189278_bb0145","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1084\/jem.20160392","article-title":"S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3\/IL-1\u03b2","volume":"214","author":"Weichand","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2025.189278_bb0150","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1158\/2326-6066.CIR-14-0115","article-title":"Immunomodulatory roles of lymphatic vessels in cancer progression","volume":"2","author":"Swartz","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbcan.2025.189278_bb0155","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.celrep.2012.01.005","article-title":"VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics","volume":"1","author":"Lund","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2025.189278_bb0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/B978-0-12-417028-5.00002-8","article-title":"Dendritic cell migration through the lymphatic vasculature to lymph nodes","volume":"120","author":"Platt","year":"2013","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0165","doi-asserted-by":"crossref","first-page":"18081","DOI":"10.18632\/oncotarget.4018","article-title":"Lymphatic dysfunction attenuates tumor immunity through impaired antigen presentation","volume":"6","author":"Kimura","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2025.189278_bb0170","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd7134","article-title":"Quality of CD8(+) T cell immunity evoked in lymph nodes is compartmentalized by route of antigen transport and functional in tumor context","volume":"6","author":"O\u2019Melia","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbcan.2025.189278_bb0175","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.4049\/jimmunol.1302492","article-title":"Steady-state antigen scavenging, cross-presentation, and CD8+ T cell priming: a new role for lymphatic endothelial cells","volume":"192","author":"Hirosue","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0180","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nri1670","article-title":"Dendritic-cell trafficking to lymph nodes through lymphatic vessels","volume":"5","author":"Randolph","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0185","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.immuni.2010.10.018","article-title":"Endothelial heparan sulfate controls chemokine presentation in recruitment of lymphocytes and dendritic cells to lymph nodes","volume":"33","author":"Bao","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2025.189278_bb0190","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041186","article-title":"Leukocyte trafficking in lymphatic vessels","volume":"12","author":"Bauer","year":"2022","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bbcan.2025.189278_bb0195","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.4049\/jimmunol.1501542","article-title":"ACKR4 on stromal cells scavenges CCL19 to enable CCR7-dependent trafficking of APCs from inflamed skin to lymph nodes","volume":"196","author":"Bryce","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0200","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal4712","article-title":"Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma","volume":"9","author":"Fankhauser","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbcan.2025.189278_bb0205","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.4049\/jimmunol.0802167","article-title":"Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via mac-1\/ICAM-1-dependent mechanism","volume":"183","author":"Podgrabinska","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(01)00150-8","article-title":"The physiology of the lymphatic system","volume":"50","author":"Swartz","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbcan.2025.189278_bb0215","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cell.2010.01.045","article-title":"Lymphangiogenesis: molecular mechanisms and future promise","volume":"140","author":"Tammela","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2025.189278_bb0220","doi-asserted-by":"crossref","first-page":"9042","DOI":"10.1073\/pnas.1219603110","article-title":"PI3K\u03b1 activates integrin \u03b14\u03b21 to establish a metastatic niche in lymph nodes","volume":"110","author":"Garmy-Susini","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2025.189278_bb0225","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ccr.2007.04.020","article-title":"Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling","volume":"11","author":"Shields","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2025.189278_bb0230","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1158\/0008-5472.CAN-08-1875","article-title":"Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype","volume":"69","author":"Issa","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189278_bb0235","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.addr.2017.07.005","article-title":"Exploiting lymphatic vessels for immunomodulation: rationale, opportunities, and challenges","volume":"114","author":"Maisel","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbcan.2025.189278_bb0240","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1084\/jem.20092465","article-title":"Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via aire-independent direct antigen presentation","volume":"207","author":"Cohen","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2025.189278_bb0245","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1182\/blood-2012-04-427013","article-title":"Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells","volume":"120","author":"Tewalt","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2025.189278_bb0250","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fimmu.2012.00305","article-title":"Lymphatic endothelial cells - key players in regulation of tolerance and immunity","volume":"3","author":"Tewalt","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0255","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1158\/0008-5472.CAN-08-4051","article-title":"Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis","volume":"69","author":"Lahdenranta","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189278_bb0260","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1158\/1078-0432.CCR-05-1077","article-title":"Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer","volume":"11","author":"Renyi-Vamos","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189278_bb0265","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1158\/0008-5472.CAN-20-0156","article-title":"Lymphatic vessels in tumor dissemination versus immunotherapy","volume":"80","author":"Vaahtomeri","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189278_bb0270","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/pcmr.12064","article-title":"Lymphatic biomarkers in primary melanomas as predictors of regional lymph node metastasis and patient outcomes","volume":"26","author":"Pasquali","year":"2013","journal-title":"Pigm. Cell Melanoma Res."},{"key":"10.1016\/j.bbcan.2025.189278_bb0275","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3892\/ol.2024.14215","article-title":"Cross-talk between lymphangiogenesis and malignant melanoma cells: new opinions on tumour drainage and immunization (review)","volume":"27","author":"Ju","year":"2024","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2025.189278_bb0280","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe4362","article-title":"Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas","volume":"7","author":"Sasso","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbcan.2025.189278_bb0285","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn8097","article-title":"Local delivery of low-dose anti-CTLA-4 to the melanoma lymphatic basin leads to systemic T(reg) reduction and effector T cell activation","volume":"7","author":"van Pul","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0290","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Saut\u00e8s-Fridman","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2025.189278_bb0295","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2025.189278_bb0300","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/j.immuni.2021.10.003","article-title":"Ileitis-associated tertiary lymphoid organs arise at lymphatic valves and impede mesenteric lymph flow in response to tumor necrosis factor","volume":"54","author":"Czepielewski","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2025.189278_bb0305","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1073\/pnas.0700334104","article-title":"Transgenic LacZ under control of Hec-6st regulatory sequences recapitulates endogenous gene expression on high endothelial venules","volume":"104","author":"Liao","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2025.189278_bb0310","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.21628","article-title":"CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia","volume":"66","author":"Berrih-Aknin","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0315","first-page":"17","article-title":"Cellular and vascular components of tertiary lymphoid structures","volume":"2018","author":"Mueller","year":"1845","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101406","article-title":"Tertiary lymphoid structures and B cells: clinical impact and therapeutic modulation in cancer","volume":"48","author":"Saut\u00e8s-Fridman","year":"2020","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0325","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ccell.2023.02.002","article-title":"High endothelial venules in cancer: regulation, function, and therapeutic implication","volume":"41","author":"Vella","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2025.189278_bb0330","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/ni1330","article-title":"Lymphoid organ development: from ontogeny to neogenesis","volume":"7","author":"Drayton","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0335","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.it.2006.08.003","article-title":"Is defective lymphatic drainage a trigger for lymphoid neogenesis?","volume":"27","author":"Thaunat","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0340","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1182\/blood-2009-12-256065","article-title":"Lymphotoxin-alpha contributes to lymphangiogenesis","volume":"116","author":"Mounzer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2025.189278_bb0345","doi-asserted-by":"crossref","first-page":"828","DOI":"10.4049\/jimmunol.1004233","article-title":"A critical role for dendritic cells in the formation of lymphatic vessels within tertiary lymphoid structures","volume":"187","author":"Muniz","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0350","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.4049\/jimmunol.1500686","article-title":"Bimodal expansion of the lymphatic vessels is regulated by the sequential expression of IL-7 and lymphotoxin \u03b11\u03b22 in newly formed tertiary lymphoid structures","volume":"197","author":"Nayar","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0355","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/cells8030270","article-title":"Two birds, one stone: double hits on tumor growth and lymphangiogenesis by targeting vascular endothelial growth factor receptor 3","volume":"8","author":"Hsu","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2025.189278_bb0360","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1158\/0008-5472.CAN-09-3488","article-title":"Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-a and VEGF-C with a receptor-immunoglobulin fusion protein","volume":"70","author":"Zhang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189278_bb0365","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/84651","article-title":"Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3","volume":"7","author":"M\u00e4kinen","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2025.189278_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011941","article-title":"Phage-derived fully human monoclonal antibody fragments to human vascular endothelial growth factor-C block its interaction with VEGF receptor-2 and 3","volume":"5","author":"Rinderknecht","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2025.189278_bb0375","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biomaterials.2017.05.026","article-title":"A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway","volume":"139","author":"Choi","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbcan.2025.189278_bb0380","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1046\/j.1432-1327.2000.01257.x","article-title":"Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3","volume":"267","author":"Achen","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbcan.2025.189278_bb0385","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1111\/cas.12010","article-title":"Inhibition of lymphatic metastasis in neuroblastoma by a novel neutralizing antibody to vascular endothelial growth factor-D","volume":"103","author":"Kashima","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2025.189278_bb0390","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/ijc.22937","article-title":"Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model","volume":"121","author":"Whitehurst","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189278_bb0395","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1186\/s12885-018-4630-0","article-title":"3-O-Acetyloleanolic acid inhibits VEGF-A-induced lymphangiogenesis and lymph node metastasis in an oral cancer sentinel lymph node animal model","volume":"18","author":"Hwang-Bo","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2025.189278_bb0400","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2025.189278_bb0405","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00280-016-3134-3","article-title":"Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856\/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer","volume":"78","author":"Saif","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0410","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13045-017-0484-1","article-title":"Targeting VEGFR-3\/\u22122 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases","volume":"10","author":"Garc\u00eda-Caballero","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0415","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/bph.13488","article-title":"Novel application assigned to toluquinol: inhibition of lymphangiogenesis by interfering with VEGF-C\/VEGFR-3 signalling pathway","volume":"173","author":"Garc\u00eda-Caballero","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0420","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3892\/ijo.2012.1603","article-title":"Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D\/VEGFR-3 with norcantharidin","volume":"41","author":"Liu","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0425","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/cr.2010.116","article-title":"VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis","volume":"20","author":"Zhang","year":"2010","journal-title":"Cell Res."},{"key":"10.1016\/j.bbcan.2025.189278_bb0430","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/cells13010068","article-title":"Dysregulation of lymphatic endothelial VEGFR3 signaling in disease","volume":"13","author":"Kuonqui","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2025.189278_bb0435","doi-asserted-by":"crossref","first-page":"14940","DOI":"10.18632\/oncotarget.3613","article-title":"Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2\/3 and TIE-2 signaling","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2025.189278_bb0440","doi-asserted-by":"crossref","first-page":"R66","DOI":"10.1186\/bcr2903","article-title":"Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3","volume":"13","author":"Kodera","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189278_bb0445","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1158\/1078-0432.CCR-07-5270","article-title":"Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase","volume":"14","author":"Matsui","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189278_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.667474","article-title":"MAZ51 blocks the tumor growth of prostate cancer by inhibiting vascular endothelial growth factor receptor 3","volume":"12","author":"Yamamura","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0455","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1158\/1535-7163.MCT-11-0866-T","article-title":"SAR131675, a potent and selective VEGFR-3-TK inhibitor with antilymphangiogenic, antitumoral, and antimetastatic activities","volume":"11","author":"Alam","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2025.189278_bb0460","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood-2005-06-2538","article-title":"Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action","volume":"107","author":"Cao","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2025.189278_bb0465","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1038\/sj.emboj.7600763","article-title":"Hepatocyte growth factor promotes lymphatic vessel formation and function","volume":"24","author":"Kajiya","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2025.189278_bb0470","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaoto.2015.2381","article-title":"Mitigation of tumor-associated fibroblast-facilitated head and neck cancer progression with anti-hepatocyte growth factor antibody ficlatuzumab","volume":"141","author":"Kumar","year":"2015","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.bbcan.2025.189278_bb0475","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1158\/1535-7163.MCT-14-0456","article-title":"Combining onartuzumab with erlotinib inhibits growth of non-small cell lung cancer with activating EGFR mutations and HGF overexpression","volume":"14","author":"Sano","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2025.189278_bb0480","article-title":"Advances in drugs targeting lymphangiogenesis for preventing tumor progression and metastasis","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0485","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1158\/1078-0432.CCR-17-1775","article-title":"Phase I study of MEDI3617, a selective angiopoietin-2 inhibitor alone and combined with carboplatin\/paclitaxel, paclitaxel, or bevacizumab for advanced solid tumors","volume":"24","author":"Hyman","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189278_bb0490","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.addr.2015.12.011","article-title":"Tumor lymphangiogenesis and new drug development","volume":"99","author":"Dieterich","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbcan.2025.189278_bb0495","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","article-title":"Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2025.189278_bb0500","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1177\/0091270011431066","article-title":"Modulation of lymphangiogenesis: a new target for aspirin and other nonsteroidal anti-inflammatory agents? A systematic review","volume":"52","author":"Yiannakopoulou","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0505","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/path.2935","article-title":"Interleukin-6 signalling regulates vascular endothelial growth factor-C synthesis and lymphangiogenesis in human oral squamous cell carcinoma","volume":"225","author":"Shinriki","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0510","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S1470-2045(17)30566-1","article-title":"Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"18","author":"Catenacci","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0515","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.684865","article-title":"Crizotinib in sarcomatous malignancies harboring ALK fusion with a definitive partner(s): response and efficacy","volume":"11","author":"Wu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0520","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s10637-020-00940-3","article-title":"Tivantinib inhibits the VEGF signaling pathway and induces apoptosis in gastric cancer cells with c-MET or VEGFA amplification","volume":"38","author":"Kim","year":"2020","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.bbcan.2025.189278_bb0525","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1158\/1078-0432.CCR-18-1341","article-title":"Phase I study of AMG 337, a highly selective small-molecule MET inhibitor, in patients with advanced solid tumors","volume":"25","author":"Hong","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189278_bb0530","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1158\/1078-0432.CCR-15-1221","article-title":"A phase I first-in-human study of nesvacumab (REGN910), a fully human anti-angiopoietin-2 (Ang2) monoclonal antibody, in patients with advanced solid tumors","volume":"22","author":"Papadopoulos","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189278_bb0535","doi-asserted-by":"crossref","first-page":"6988","DOI":"10.1158\/0008-5472.CAN-16-0888","article-title":"Efficacy of cotargeting angiopoietin-2 and the VEGF pathway in the adjuvant postsurgical setting for early breast, colorectal, and renal cancers","volume":"76","author":"Wu","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189278_bb0540","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s10439-024-03523-y","article-title":"Low-intensity pulsed ultrasound: a physical stimulus with immunomodulatory and anti-inflammatory potential","volume":"52","author":"Liang","year":"2024","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.bbcan.2025.189278_bb0545","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/php.13598","article-title":"The effect of low-level laser therapy on VEGF, IL-6 expression and viability of oral squamous cell carcinoma cells","volume":"98","author":"Mansourian","year":"2022","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19336918.2023.2271260","article-title":"Lymphangiogenic responses of lymphatic endothelial cells to steady direct-current electric fields","volume":"17","author":"Guan","year":"2023","journal-title":"Cell Adhes. Migr."},{"key":"10.1016\/j.bbcan.2025.189278_bb0555","doi-asserted-by":"crossref","first-page":"7747","DOI":"10.3390\/ijms22147747","article-title":"Extracellular Hsp90\u03b1 promotes tumor lymphangiogenesis and lymph node metastasis in breast cancer","volume":"22","author":"Hou","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189278_bb0560","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3390\/cancers15041169","article-title":"Current status of lymphangiogenesis: molecular mechanism, immune tolerance, and application prospect","volume":"15","author":"Deng","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189278_bb0565","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3390\/cancers10110413","article-title":"Mechanisms of lysophosphatidic acid-mediated lymphangiogenesis in prostate cancer","volume":"10","author":"Wu","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189278_bb0570","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.canlet.2013.12.001","article-title":"Hypoxia and lymphangiogenesis in tumor microenvironment and metastasis","volume":"346","author":"Ji","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2025.189278_bb0575","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1182\/blood-2012-11-466532","article-title":"Neutrophils contribute to inflammatory lymphangiogenesis by increasing VEGF-A bioavailability and secreting VEGF-D","volume":"122","author":"Tan","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2025.189278_bb0580","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2493","article-title":"Role of the VEGF in virus-associated cancers","volume":"34","author":"Tavakolian","year":"2024","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0585","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.addr.2020.08.013","article-title":"Imaging technology of the lymphatic system","volume":"170","author":"Polomska","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbcan.2025.189278_bb0590","doi-asserted-by":"crossref","DOI":"10.1111\/micc.12780","article-title":"Recent advancement of imaging strategies of the lymphatic system: answer to the decades old questions","volume":"29","author":"Banerjee","year":"2022","journal-title":"Microcirculation"},{"key":"10.1016\/j.bbcan.2025.189278_bb0595","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/lrb.2017.29031.sr","article-title":"A role for near infrared fluorescent imaging in the evaluation of lymphatic function","volume":"15","author":"Rockson","year":"2017","journal-title":"Lymphat. Res. Biol."},{"key":"10.1016\/j.bbcan.2025.189278_bb0600","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/jmri.27069","article-title":"Magnetic resonance lymphangiography of the central lymphatic system: technique and clinical applications","volume":"53","author":"Pabon-Ramos","year":"2021","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.bbcan.2025.189278_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113833","article-title":"Physiological models for in vivo imaging and targeting the lymphatic system: nanoparticles and extracellular vesicles","volume":"175","author":"Olmeda","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbcan.2025.189278_bb0610","first-page":"795","article-title":"Bacterial therapy: a promising strategy for cancer immunotherapy","volume":"20","author":"Wang","year":"2023","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.bbcan.2025.189278_bb0615","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.3390\/molecules25204831","article-title":"Targeting metabolism in cancer cells and the tumour microenvironment for cancer therapy","volume":"25","author":"Li","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bbcan.2025.189278_bb0620","doi-asserted-by":"crossref","DOI":"10.1002\/INMD.20230047","article-title":"CAR-T-cell products in solid tumors: progress, challenges, and strategies","volume":"2","author":"Qian","year":"2024","journal-title":"Interdisciplin. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25000204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25000204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T11:08:05Z","timestamp":1742296085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X25000204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":124,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0304419X25000204"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189278","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphangiogenesis orchestrating tumor microenvironment: Face changing in immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189278","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189278"}}